Women who suffer from sensory loss more likely to report depression and anxiety

Women who suffer from vision, hearing or dual sensory loss are more than twice as likely to report depression and anxiety as men who experience the same issues, according to a new study by Anglia Ruskin University (ARU).

The research, which has been published in the International Journal of Geriatric Psychiatry, looked at survey data from more than 23,000 adults, where participants had self-reported whether they had suffered depression or anxiety, and also whether they experienced vision, hearing, or dual (both vision and hearing) sensory impairment.

Across the whole sample, the prevalence of depression and anxiety was between 2 and 2.56 higher in women compared to men.

Women with dual sensory impairment were almost three and a half times more likely to report depression or anxiety than those who did not have any impairments, while men with dual sensory impairment were more than two and a half times more likely to experience depression, and almost twice as likely to report anxiety than those with no impairment.

Our study found that while sensory loss, particularly both vision and hearing loss, results in a higher number of the population reporting depression and anxiety, the association is particularly strong in women.

This highlights the importance of interventions to address vision and hearing loss, especially in women. Some sensory loss is preventable or treatable, and clearly these issues are taking their toll not just on physical health, but mental health too."

Professor Shahina Pardhan, Lead Author, Director of the Vision and Eye Research Institute, ARU

The study used data from the Spanish National Health Survey.

Source:
Journal reference:

Pardhan, S., et al. (2021) Visual, hearing, and dual sensory impairment are associated with higher depression and anxiety in women. International Journal of Geriatric Psychiatry. doi.org/10.1002/gps.5534.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study provides insight into how low-dose ketamine alleviates symptoms of major depression